Search

Showing "11155" results for ""

IAS: Tipranavir combined with T-20 achieves good virologic results in the highly treatment experienced

IAS: Two studies suggest that it may be possible to screen for acute primary HIV infections in sub-Saharan Africa

IAS: Remaining on 3TC despite resistance leads to better immunological and clinical outcomes

IAS: New tablet formulation of Kaletra is on its way, manufacturer says

IAS: ‘Next generation’ NNRTI GW695634 is safe and active in NNRTI-resistant patients

IAS: Needle-free T-20 delivery reduces, but does not eliminate, injection site reactions (corrected)

IAS: Remune slows viral load rise and CD4 cell count fall during treatment interruptions

IAS: New NRTI D-d4FC active in treatment-experienced patients

UK international HIV funding increased

IAS: Virological failure rare in patients taking saquinavir / ritonavir

IAS: Use of crystal methamphetamine boosts risk of transmitting drug-resistant HIV

IAS: Kidney disease may be highly prevalent amongst HIV-infected in Africa

IAS: HPV infection is an independent risk factor for HIV

IAS: TMC114 plus low-dose ritonavir effective and well-tolerated in 3-class-experienced HIV patients

IAS: Routine thyroid testing advised for people taking antiretrovirals

IAS: Columbia University is coordinating treatment scale at multiple sites in several sub-Saharan African countries

IAS: 3TC infant prophylaxis during breast-feeding reduces HIV infection rate at six months

IAS: Study in Côte d’Ivoire describes factors associated with survival in older children with HIV: not all respond to treatment

Receive the latest HIV research and conference news

Showing "11155" results for ""

IAS: Tipranavir combined with T-20 achieves good virologic results in the highly treatment experienced

IAS: Two studies suggest that it may be possible to screen for acute primary HIV infections in sub-Saharan Africa

IAS: Remaining on 3TC despite resistance leads to better immunological and clinical outcomes

IAS: New tablet formulation of Kaletra is on its way, manufacturer says

IAS: ‘Next generation’ NNRTI GW695634 is safe and active in NNRTI-resistant patients

IAS: Needle-free T-20 delivery reduces, but does not eliminate, injection site reactions (corrected)

IAS: Remune slows viral load rise and CD4 cell count fall during treatment interruptions

IAS: New NRTI D-d4FC active in treatment-experienced patients

UK international HIV funding increased

IAS: Virological failure rare in patients taking saquinavir / ritonavir

IAS: Use of crystal methamphetamine boosts risk of transmitting drug-resistant HIV

IAS: Kidney disease may be highly prevalent amongst HIV-infected in Africa

IAS: HPV infection is an independent risk factor for HIV

IAS: TMC114 plus low-dose ritonavir effective and well-tolerated in 3-class-experienced HIV patients

IAS: Routine thyroid testing advised for people taking antiretrovirals

IAS: Columbia University is coordinating treatment scale at multiple sites in several sub-Saharan African countries

IAS: 3TC infant prophylaxis during breast-feeding reduces HIV infection rate at six months

IAS: Study in Côte d’Ivoire describes factors associated with survival in older children with HIV: not all respond to treatment

Receive the latest HIV research and conference news